黑色素瘤及妊娠相关黑色素瘤中G蛋白偶联雌激素受体的表达
该研究采用免疫组化检测81例黑色素瘤组织中GPER、ERα和ERβ蛋白水平,比较妊娠相关黑色素瘤(PAM,n=38)与年龄及Breslow厚度匹配的非妊娠相关黑色素瘤(NPAM,n=43)的表达差异及其与无病生存期(DFS)的关系。发现GPER与ERβ共表达在PAM中更常见,且GPER/ERβ阳性与较低的Breslow厚度、较低核分裂率及较高瘤周淋巴细胞浸润相关,预测更好的DFS(HR=0.785,95%CI 0.582-1.058)。
要点
- GPER在PAM和NPAM中均可检测到,且常与ERβ共表达。
- GPER/ERβ阳性黑色素瘤在PAM中显著多于NPAM(P=0.0001)。
- GPER/ERβ阳性与较低Breslow厚度、较低核分裂率及较高瘤周淋巴细胞浸润相关,预测更好DFS。
核心结论
- GPER及其与ERβ的共表达可作为部分黑色素瘤患者新的预后指标。
研究设计与样本
- 免疫组化检测81例福尔马林固定石蜡包埋黑色素瘤组织中GPER、ERα和ERβ蛋白水平。
- PAM(n=38)与年龄和Breslow厚度匹配的NPAM(n=43,包括非妊娠女性n=22和男性n=21)进行比较。
- 采用单因素和多因素Cox比例风险回归分析受体表达与DFS的关联。
主要发现
- 41例GPER阳性黑色素瘤中39例(95.1%)共表达ERβ。
- GPER/ERβ阳性黑色素瘤在PAM中较NPAM更常见(P=0.0001),性别间无显著差异(P=0.4383)。
- PAM中GPER与ERβ分布相似(78.4% vs. 81.6%;P=0.8504),NPAM中ERβ为代表受体(60.5% vs. 27.9%;P=0.0010),无性别差异(59.1% vs. 61.9%)。
- GPER-/ERβ阳性黑色素瘤与较低Breslow厚度、较低核分裂率及较高瘤周淋巴细胞浸润相关(P=0.0156、P=0.0036和P=0.0001),预测更好DFS(HR=0.785,95%CI 0.582-1.058)。
- 尽管PAM中GPER和ERβ表达频率显著更高,但PAM与NPAM间DFS无显著差异。
临床怎么用
- GPER/ERβ共表达检测可能有助于黑色素瘤预后分层。
- 妊娠相关黑色素瘤中GPER/ERβ阳性更常见,但DFS与NPAM无显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The hormone sensitivity of melanoma and the role of 'classical' oestrogen receptor (ER) α and β in tumour progression have been intensively studied with rather contradictory results. The presence of 'non-classical' G protein-coupled oestrogen receptor (GPER) has not been investigated on human melanoma tissues. OBJECTIVE: To analyse the expression of GPER, ERα and ERβ in pregnancy-associated (PAM) and in non-pregnancy-associated (NPAM) melanomas in correlation with traditional prognostic markers and disease-free survival (DFS). METHODS: Receptor protein levels were tested using immunohistochemistry in 81 formalin-fixed paraffin-embedded melanoma tissues. PAMs (n = 38) were compared with age- and Breslow thickness-matched cases (n = 43) including non-pregnant women (NPAM-W) (n = 22) and men (NPAM-M) (n = 21). The association between receptor expression and DFS was analysed by uni- and multivariate Cox proportional hazards regression. RESULTS: G protein-coupled oestrogen receptor was detected both in PAMs and NPAMs. In 39 of the 41 (95.1%) GPER-positive melanomas, GPER and ERβ were co-expressed. GPER/ERβ-positive melanomas were significantly more common in PAM compared to NPAM (P = 0.0001) with no significant difference between genders (P = 0.4383). In PAMs, the distribution of GPER and ERβ was similar (78.4% vs. 81.6%; P = 0.8504), while in NPAM, ERβ was the representative ER (60.5% vs. 27.9%; P = 0.0010) without gender difference (59.1% vs. 61.9%). GPER-/ERβ-positive melanomas were associated with lower Breslow thickness, lower mitotic rate and higher presence of peritumoral lymphocyte infiltration (PLI) compared to GPER-/ERβ-negative cases (P = 0.0156, P = 0.0036 and P = 0.0001) predicting a better DFS (HR = 0.785, 95% CI 0.582-1.058). Despite the significantly higher frequency of GPER and ERβ expression in PAM, no significant difference was found in DFS between PAM and NPAM. All but one case failed to show ERα expression. CONCLUSIONS: The presence of GPER and its simultaneous expression with ERβ can serve as a new prognostic indicator in a significant subpopulation of melanoma patients.
引用
- Fábián M, Rencz F, Krenács T, et al. Expression of G protein-coupled oestrogen receptor in melanoma and in pregnancy-associated melanoma. J Eur Acad Dermatol Venereol. 2017. PMID: 28467693. doi:10.1111/jdv.14304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。